Pharmafile Logo
Pharmafocus logo
Advanced Search
brain-770044_960_720

Placebo discovery could change how clinical trials operate

October 28, 2016
Medical Communications Northwestern Medicine, Rehabilitation Institute of Chicago, brain, fMRI, pain relief

Researchers from Northwestern Medicine and the Rehabilitation Institute of Chicago (RIC) have pinpointed, for the first time, exactly which region …

News
microsoft_sign_on_german_campus

Adents and Microsoft pool resources to create new cloud platform

October 27, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Adents, EU, France, Microsoft

Adents, a French software developer for unique production identification and ‘Track & Trace’ solutions, and Microsoft have developed, with an …

News
aedes_aegypti_mosquito

Sanofi forms new alliance to fight zika in Brazil

October 27, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Zika

Sanofi has teamed up with Brazilian research institute Fiocruz to accelerate development of a zika vaccine.This is another step in …

News
teva_copy

Teva team up with IBM to tackle two challenges facing the pharma industry

October 27, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cloud Computing, Teva Pharmaceutical, asthma, ibm

Teva Pharmaceuticals and IBM have announced a partnership that will use IBM Watson Health Cloud with the aim of finding …

News
shutterstock_359806121

Oxford Genetics gets further £1 million investment boost

October 27, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Mercia Technologies, Oxford Genetics, synthetic biology

Warwickshire-based biotech Mercia Technologies has injected a further £1 million into synthetic biology- specialist Oxford Genetics, bringing their total investment …

News
cq5dam

AZ reveals compelling PhIII data for ovarian cancer treatment

October 26, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AZ, AstraZeneca, lynparza

AstraZeneca has revealed new results from a Phase III trial investigating the efficacy of its Lynparza drug as a monotherapy …

News
19199400883_6db786ce0d_b

Price hiking: US pharma’s elephant in the room

October 26, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bernie Sanders, Martin Shkreli, Mylan, Sanofi, Turing Pharmaceuticals, price hikes

Mylan’s recent EpiPen price inflation scandal has reignited a seemingly never-ending debate on the power of drug companies to charge …

Feature
november_2016_front_page

The November Issue of Pharmafocus is now live!

October 26, 2016
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Pharmafocus, features, latest news, news

The latest issue of Pharmafocus is now live and ready to be read! We’ve taken the opportunity to cover some of …

News
nordicnanovector_final_logo

Nordic Nanovector to collaborate with Heidelberg Pharma to develop leukaemia treatment

October 26, 2016
Research and Development Nordic Nanovector, WILEX, heidelberg pharma, leukaemia

Nordic Nanovector has announced that they have formed a partnership with WILEX subsidiary, Heidelberg Pharma. Heidelberg Pharma specialises in the …

News
shutterstock_57369385

NHS suppliers investigated over 1000% price hikes

October 26, 2016
Research and Development, Sales and Marketing NHS, price hikes

The Competition and Marketing Authority has launched an investigation into a number of drug companies following claims that 32 drugs …

News
runners-888021_960_720

Backlash over testosterone replacement drugs builds with FDA warnings

October 26, 2016
Research and Development FDA, FDA Warning, low t, prescription testosterone

The backlash against the over-prescription of ‘testosterone boosters’ continues in the US, with the FDA taking action to add clear …

News
f_44933

New UK research illuminates new developments for anticancer treatment

October 26, 2016
Research and Development anticancer

New research from the University of Huddersfield has shed light on a new lab technique which could aid in the …

News
merck_and_co

MSD’s Keytruda given first FDA approval for first line treatment

October 25, 2016
Manufacturing and Production BMS, MSD, NSCLC, keytruda, opdivo

MSD, known as Merck in the US, has scored a big success in treating non-small cell lung cancer (NSCLC), with …

News
novartis_outside_1

Novartis rides out fiscal hardship to beat Q3 forecasts

October 25, 2016
Manufacturing and Production, Sales and Marketing Entresto, Gleevec, Novartis

Novartis has beaten its third-quarter sales projections, announcing that new product growth and cost cuts managed to carry the company …

News
stocks1

Dr Reddy’s Laboratories profits drop 60%

October 25, 2016
Manufacturing and Production, Sales and Marketing Dr Reddy's Laboratories

Indian pharmaceutical firm Dr Reddy’s Laboratories has suffered a drop of 60.12% in consolidated net profit for the September quarter. …

News
ema_inside

EMA opens clinical trial data to public

October 25, 2016
Manufacturing and Production Amgen, AstraZeneca, EMA, EU, Kyprolis, clinical reports, clinical trials

The European Medicine Agency has begun to release to the public data on clinical trial via their own website. The …

News
logo-int-corp2

Concordia founder resigns and will step down once replacement found

October 25, 2016
Manufacturing and Production CEO, Concordia, Mark Thompson, Valeant

Concordia International Corp., the Ontario-based company, has announced that its founder, Chairman and Chief Executive Officer, Mark Thompson, will leave …

News
stocks1

Colombian pharma market to break $7 billion by 2020

October 24, 2016
Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Colombia, market report

According to new findings from GlobalData, the Colombian pharmaceutical market is due to grow from $5 billion in 2015 to …

News
opdivo_1

FDA accepts another Opdivo indication for priority review

October 24, 2016
Sales and Marketing BMS, Bristol-Myers Squibb, FDA, opdivo

The FDA has accepted a supplemental Biologics License Application (sBLA) for Bristol-Myers Squibb’s Opdivo for treatment of locally advanced unresectable …

News
merck_incweb

MSD’s Keytruda early success ends trial early

October 24, 2016
Sales and Marketing MSD, Merck, Roche, keytruda, opdivo, tecentriq

MSD, known as Merck in the US, ended their Phase III trial of Keytruda for treatment of advanced urothelial cancer …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026